+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cytomegalovirus (CMV) Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033

  • PDF Icon


  • June 2023
  • Region: Global
  • GlobalData
  • ID: 5600209
1h Free Analyst Time

Quick Summary:

As leaders in the healthcare industry, an in-depth understanding of diagnostic advancements is key to strategic planning and investment. The Cytomegalovirus (CMV) Tests Market Report presents comprehensive, quantitative and qualitative analysis on the global CMV tests industry, ensuring a thorough visualization of market trends within the In Vitro Diagnostics therapeutic area. This detailed analysis majorly speaks to CMO executives, sourcing and procurement heads, and private equity investors needing crucial insights to make informed decisions.

The report delivers unparalleled understanding of the CMV tests market, providing a detailed drill-down into key industry trends, revenue distribution, and a full ground-up understanding of the CMV Testing market, enhanced by a SWOT analysis and competitive dynamics insights. Aimed at driving understanding of market dynamics, you'll delve into specifics such as reimbursement policies and the regulatory landscape, particularly at the country level. This insightful given report will not only allow you to make strategic decisions but also help you identify emerging players, anticipate innovative products and technologies, and recognize market segments and companies with a potential for impactful future role. Leverage this value-added information to gain a competitive advantage and seize sales and marketing opportunities.

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cytomegalovirus (CMV) Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Cytomegalovirus(CMV) tests market for the year 2020 and beyond. Cytomegalovirus(CMV) tests are performed for detection of Cytomegalovirus. The CMV infections are mostly prevalent in pregnant women, immunocompromised patients and infants. The tests carried out in laboratories are considered.

The CMV tests include Enzyme Immuno Assay (EIA) Tests, Nucleic Acid Amplification Tests (NAATs) and other CMV test kits.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Cytomegalovirus(CMV) tests and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total Cytomegalovirus(CMV) tests market revenue by segment and market outlooks from 2015-2033.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, publisher analysts provide unique country specific insights on the market.
  • SWOT analysis for Cytomegalovirus market.
  • Competitive dynamics insights and trends provided for Cytomegalovirus market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, StatLab Medical (SLMP), Danaher Corp,MBL International Corporation, bioMerieux SA, Bio-Rad Laboratories Inc, DiaSorin SpA, Erba Diagnostics Mannheim GmbH, Immucor Inc, Luminex Corp, E. Merck KGaA, Qiagen NV, Quidelortho Corp, Altona Diagnostic GmbH, F. Hoffmann-La Roche Ltd, Siemens AG, Trinity Biotech Plc., and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile


This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the Cytomegalovirus (CMV) Tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on Cytomegalovirus (CMV) Tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Cytomegalovirus (CMV) Tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cytomegalovirus (CMV) Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Cytomegalovirus (CMV) Tests market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

  • Not Applicable

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • American Master Tech Scientific Inc
  • Danaher Corp
  • bioMerieux SA
  • MBL International Corporation
  • Bio-Rad Laboratories Inc
  • DiaSorin SpA
  • Erba Diagnostics Mannheim GmbH
  • Immucor Inc
  • Luminex Corp
  • Merck KGaA
  • Qiagen NV
  • Quidelortho Corp
  • Altona Diagnostic GmbH
  • F. Hoffmann-La Roche Ltd
  • Siemens AG
  • Trinity Biotech Plc.